4 results match your criteria: "VA Memphis Medical Center[Affiliation]"

Infective endocarditis (IE) caused by is a rare but serious condition if not diagnosed and treated promptly. In this article, we describe a patient with IE who initially presented with non-specific symptoms but subsequently developed multiple sequelae of IE. The diagnosis of IE was made based on clinical, echocardiographic, radiological and microbiological findings.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to investigate the relationship between Meibomian gland dysfunction (MGD) features, ocular surface symptoms, and tear cytokines in individuals with dry eye conditions.
  • Researchers assessed 40 South Florida veterans, analyzing factors like eyelid vascularity, meibum quality, and MG dropout in relation to dry eye symptoms and tear inflammation-related proteins.
  • Results showed that eyelid vascularity was significantly associated with increased inflammation markers, indicating that various MGD characteristics may have distinct underlying biological causes.
View Article and Find Full Text PDF

Self/informant-report and performance-based instruments are typically used to measure activities of daily living (ADLs) and instrumental activities of daily living (IADLs). Minimal attention has focused on clinician-rated measures. Executive functioning (EF) contributes significantly to functional independence, and the validity of functional status measures has been examined through its relationship to EF scores.

View Article and Find Full Text PDF

Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study.

Am Heart J

December 2018

Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Division of Cardiovascular Medicine Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Observational, genetic, and experimental data indicate that triglyceride rich lipoproteins (TRLs) likely participate causally in atherothrombosis. Yet, robust clinical trial evidence that triglyceride (TG) lowering therapy reduces cardiovascular events remains elusive. The selective peroxisome proliferator-activated receptor alpha modulator (SPPARM-α), pemafibrate, will be used to target residual cardiovascular risk remaining after treatment to reduce low-density lipoprotein cholesterol (LDL-C) in individuals with the dyslipidemia of type 2 diabetes mellitus (T2).

View Article and Find Full Text PDF